Evidence map›Paper›PMID 39234197›Full record

ReviewAging medicine (Milton (N.S.W))2024

The increasing prevalence of cancer in the elderly: An investigation of epidemiological trends.

Ramya Prathap, Sherlin Kirubha, Aravindhan Thiyaga Rajan, Santhosh Manoharan, Karthikeyan Elumalai

Abstract readReview
In one paragraph

Review in Aging medicine (Milton (N.S.W)), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Access to Supportive Care Among Australian Cancer Carers: Experiences of Priority Populations.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  3. Article
  4. Article
  5. Return to work in elderly population with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ramya PrathapDepartment of Pharmaceutical Chemistry, Saveetha College of Pharmacy Saveetha Institute of Medical and Technical Sciences Chennai India.
Sherlin KirubhaDepartment of Pharmaceutical Chemistry, Saveetha College of Pharmacy Saveetha Institute of Medical and Technical Sciences Chennai India.
Aravindhan Thiyaga RajanDepartment of Pharmaceutical Chemistry, Saveetha College of Pharmacy Saveetha Institute of Medical and Technical Sciences Chennai India.
Santhosh ManoharanDepartment of Pharmaceutical Chemistry, Saveetha College of Pharmacy Saveetha Institute of Medical and Technical Sciences Chennai India.
Karthikeyan ElumalaiDepartment of Pharmaceutical Chemistry, Saveetha College of Pharmacy Saveetha Institute of Medical and Technical Sciences Chennai India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer poses a significant health threat to the elderly, accounting for a substantial proportion of cancer patients aged 65 and above. As life expectancy continues to rise and the population ages, the incidence of cancer in the elderly is expected to increase further. Age is a major risk factor for the majority of common cancers, with the incidence and prevalence rising as individuals grow older. Factors such as chemoprevention and environmental carcinogen elimination may influence the process of carcinogenesis. Studies reveal that the incidence and mortality rates of various cancers in the elderly and extremely old individuals are on the rise worldwide, with most types peaking around the age of 75 to 90, followed by a sharp decline. Birth cohort and period effects also play a complex role in the connection between aging and cancer risk. Clinical trials often exclude older individuals, limiting our understanding of cancer treatments' effects on this particular age group. More research is needed to focus on the unique requirements of older adults with cancer.

Indexed as

cancerclinical trialselderly patientspolypharmacy

Identifiers

PMID39234197
PMCPMC11369332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.